1 min left

0% read

BioXcel Therapeutics

Analytics

Infrastructure

Software

Analytics Provider

New Haven, Connecticut, USA

Founded 2017

BioXcel Therapeutics Overview

BioXcel Therapeutics, Inc. is a clinical-stage biopharmaceutical company utilizing artificial intelligence approaches to develop transformative medicines in neuroscience and immuno-oncology. BioXcel's drug re-innovation approach leverages existing approved drugs and/or clinically validated product candidates together with big data and proprietary machine learning algorithms to identify new therapeutic indices.

BioXcel's two most advanced clinical development programs are:

BXCL501, an investigational, proprietary, orally dissolving thin film formulation of dexmedetomidine for the treatment of agitation and opioid withdrawal symptoms.
BXCL701, an investigational, orally administered, systemic innate immunity activator in development for the treatment of aggressive forms of prostate cancer and advanced solid tumors that are refractory or treatment naïve to checkpoint inhibitors.

Frequently Asked Questions About BioXcel Therapeutics

BioXcel Therapeutics is a company in the cryptocurrency and blockchain space. Visit their profile on Crypto News Navigator for details about their services, team, and company background.

BioXcel Therapeutics has been operating since 2017. You can verify their legitimacy through their official website and social media presence.

BioXcel Therapeutics operates in the analytics sector of the cryptocurrency industry. Compare BioXcel Therapeutics with other analytics companies on Crypto News Navigator to evaluate services, features, and reputation before making your decision.

Before using BioXcel Therapeutics, research their track record (operating since 2017), verify their regulatory compliance, read user reviews, and understand their fee structure. Never share your private keys with any service, and start with small amounts until you are comfortable with the platform.

Safety depends on multiple factors including regulatory compliance, security practices, and track record. BioXcel Therapeutics is based in New Haven, Connecticut, USA, has been operating since 2017. Always enable two-factor authentication, use strong passwords, and never store large amounts on any third-party platform.

BioXcel Therapeutics is based in New Haven, Connecticut, USA, North America.

BioXcel Therapeutics was founded in 2017. The company currently has 99 employees.

BioXcel Therapeutics Details

BioXcel Therapeutics Tags

More About BioXcel Therapeutics

Work Model Details

Employees work from physical offices.

Latest from Academy

Altcoins

Bitcoin Maxis Built the SATS Brand and a Token Ate

A pseudonymous developer named Baba was hyping a BRC-20 token in December 2023 that he had recently deployed from a project playing around with Bitcoin's Ordinals protocol. The token was called 1000SATS, and it would hit an all-time high price of $0.0009261 later that year. The SATS token is now trading at $0.00001071, down about 98.8% from its all-time high. The sats meme that once rallied an entire movement now poses a more nihilistic question: did the culture eat itself?

Katerina Kulikovska15h ago

8m read

Trading Analysis

Four Catalysts Could Push PAX Gold Past $5,200 by 2027

PAXG is not a stablecoin. It's a tokenized commodity that has all the upside of gold and is by no means topped out near $4,556 as of April 2. Any realistic price target model for where Pax Gold price will be in 12-18 months needs to account for 4 unique catalysts that have not yet fully played out. If all 4 catalysts begin to kick in, $5,200 wouldn't just be possible, it'd be expected.

Crypto News Navigator17h ago

8m read

Blockchain

Why Circle and Paxos Both Chose Aleo for Stablecoins

By 2025, stablecoins will have been traded $33 trillion. Less than 1% of businesses issue employee salaries in cryptocurrency. The biggest blocker is that sending salary payments, vendor invoices, and treasury balances on public blockchains exposes that information to anyone who pulls it up on a block explorer. Privacy-focused Layer 1 Aleo was made for enterprises trying to solve this problem.

Mia HallandApr 9, 2026

10m read